MENU
RNAZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TransCode Therapeutics (RNAZ) Ownership - Who owns TransCode Therapeutics?

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer... Show more

Profile

Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.04M
P/E Ratio
0.00
Total Cash
5.81M
Projected Growth
N/A
Total Debt
38.29K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.97
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

RNAZ
Capitalization
6.04M
P/E Ratio
0.00
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.81M
Total Cash/Share
6.97
Total Debt
38.3K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.02M
P/B Ratio
0.59
Cash Flow
N/A
Earnings
-1.32K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103
Current Ratio
2.56
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-269.34
Shares Held By Institutions
N/A
Shares Outstanding - Current
834K
Total Liabilities
9.31M
Total Volume MTD
N/A
Value
1
Gain YTD
-92.317
View a ticker or compare two or three
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com